Health Dictionary Find a Doctor

Incidentaloma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]

Overview

Overview

If left untreated, patients with adrenal incidentaloma may progress to develop dyslipidemiaosteoporosishyperglycemiamalignant hypertensionintracranial hemorrhageacute coronary syndromeaortic dissectionmalignant transformation, and metastasis. Prognosis is usually good in benign adrenal incidentalomas, death is not directly related to the adrenal mass, but to cardiovascular accidents, malignancy, and chronic disorders, as observed in the general population. Adrenocortical carcinoma (ACC) carries a poor prognosis and is unlike most tumors of the adrenal cortex, which are benign (adenomas) and only occasionally cause Cushing’s syndrome.

Natural History, Complications, and Prognosis

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

Adrenocortical carcinoma (ACC) carries a poor prognosis and is unlike most tumors of the adrenal cortex, which are benign (adenomas) and only occasionally cause Cushing’s syndrome. Adrenal mass size is important because the smaller the adrenocortical carcinoma is at the time of diagnosis, the better the overall prognosis.[5]

References

References

  1. Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM (1991). “Incidentally discovered adrenal tumors: an institutional perspective”. Surgery. 110 (6): 1014–21. PMID 1745970.
  2. Barzon L, Fallo F, Sonino N, Boscaro M (2002). “Development of overt Cushing’s syndrome in patients with adrenal incidentaloma”. Eur J Endocrinol. 146 (1): 61–6. PMID 11751069.
  3. Bondanelli M, Campo M, Trasforini G, Ambrosio MR, Zatelli MC, Franceschetti P; et al. (1997). “Evaluation of hormonal function in a series of incidentally discovered adrenal masses”. Metabolism. 46 (1): 107–13. PMID 9005978.
  4. Dekkers OM, Horváth-Puhó E, Jørgensen JO, Cannegieter SC, Ehrenstein V, Vandenbroucke JP; et al. (2013). “Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study”. J Clin Endocrinol Metab. 98 (6): 2277–84. doi:10.1210/jc.2012-3582. PMID 23533241.
  5. Barry MK, van Heerden JA, Farley DR, Grant CS, Thompson GB, Ilstrup DM (1998). “Can adrenal incidentalomas be safely observed?”. World J Surg. 22 (6): 599–603, discussion 603-4. PMID 9597935.

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH